Home > Insider Trading > Filing (0000874716-25-000126)

Filing Details

Accession Number:: 0000874716-25-000126
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-08-08 20:38:08
Reporting Period:: 2025-08-06

Filing Date:: 2025-08-08
Accepted Time:: 2025-08-08 20:38:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1556270	Jay Jonathan Mazelsky	One Idexx Drive Westbrook ME 04092	President And Ceo	Yes	Yes	No	No

Transaction Summary

Sold:	29,260 shares	Avg. Price: $631.98	Total Value: $18,491,642.25
Number of Shares After Transactions:	83,311 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-08-06	29,260	$67.85	112,571	No	4	M	Direct
Common Stock	Disposition	2025-08-06	1,095	$626.90	111,476	No	4	S	Direct
Common Stock	Disposition	2025-08-06	1,525	$628.27	109,951	No	4	S	Direct
Common Stock	Disposition	2025-08-06	3,397	$629.82	106,554	No	4	S	Direct
Common Stock	Disposition	2025-08-06	6,056	$630.59	100,498	No	4	S	Direct
Common Stock	Disposition	2025-08-06	7,299	$631.61	93,199	No	4	S	Direct
Common Stock	Disposition	2025-08-06	3,000	$632.56	90,199	No	4	S	Direct
Common Stock	Disposition	2025-08-06	3,526	$635.13	86,673	No	4	S	Direct
Common Stock	Disposition	2025-08-06	1,822	$636.15	84,851	No	4	S	Direct
Common Stock	Disposition	2025-08-06	880	$636.81	83,971	No	4	S	Direct
Common Stock	Disposition	2025-08-06	660	$639.37	83,311	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2025-08-06	29,260	$0.00	29,260	$67.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-13	No	4	M	Direct

Footnotes

Includes 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
Represents the weighted average price of the shares sold ranging from a low of $626.585 to a high of $627.44 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $627.72 to a high of $628.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $629.14 to a high of $630.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $630.14 to a high of $630.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $631.26 to a high of $632.15 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $632.41 to a high of $633.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $634.66 to a high of $635.64 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $635.66 to a high of $636.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $636.66 to a high of $637.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $639.235 to a high of 639.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 41,260 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2017.
Not applicable